AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Cancer Biology & Medicine Article
PDF (141.9 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Erratum | Open Access

Erratum to Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA

Kenan Zhang1, Xing Liu2, Guanzhang Li1,3, Xin Chang4, Shouwei Li4, Jing Chen1, Zheng Zhao1, Jiguang Wang5,6,7, Tao Jiang1,3( ), Ruichao Chai1,2,5( )
Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
Department of Neurosurgery, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing 100093, China
Division of Life Science and State Key Laboratory of Molecular Neuroscience, Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR 999077, China
Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong SAR 999077, China
HKUST Shenzhen-Hong Kong Collaborative Innovation Research Institute, Futian, Shenzhen 518057, China
Show Author Information
The online version of the original article can be found at:
https://doi.org/10.20892/j.issn.2095-3941.2022.0469

Keywords

temozolomideDiffuse gliomaIDH1p/19qmolecular pathology

References

1

Zhang K, Liu X, Li G, Chang X, Li S, Chen J, et al. Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA. Cancer Biol Med. 2022; 19: 1460-76.
Crossref Google Scholar
Cancer Biology & Medicine
Volume 20 Issue 7,
July 2023
Pages 537-537
DOI: 10.20892/j.issn.2095-3941.2023.0227
Cite this article:
Zhang K, Liu X, Li G, et al. Erratum to Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA. Cancer Biology & Medicine, 2023, 20(7): 537. https://doi.org/10.20892/j.issn.2095-3941.2023.0227

53

Views

0

Downloads

0

Crossref

1

Web of Science

0

Scopus

Altmetrics
Published: 01 July 2023
©2023 Cancer Biology & Medicine.

Creative Commons Attribution-NonCommercial 4.0 International License
Return